- ChristophMcLee   Oct 17, 2017 at 10:37: AM
ChristophMcLee
new user
Johnson&Johnson is discontinuing clinical trials on two potentially blockbuster drugs. Bad timing I would say. I wonder how the company plans to maintain its growth in Pharma sales without these drugs.
Source Article
Source Article